This HTML5 document contains 69 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q86503109
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel scientific article published on 19 February 2013 artículu científicu espublizáu en febreru de 2013 наукова стаття, опублікована в лютому 2013
p:P577
wds:Q86503109-A1E7D8F4-3D27-4DBC-B082-C2C7090BD5AD
wdt:P577
2013-02-19T00:00:00Z
p:P2093
wds:Q86503109-15333BE7-9FCF-465B-84C0-77B90AE47DE7 wds:Q86503109-4A5EE21B-5D40-4946-B18E-27189F42F33E wds:Q86503109-A88FB1C7-B775-449D-98ED-60387986F987 wds:Q86503109-BE732702-5128-465F-A59F-24AC7745A15F wds:Q86503109-CFE798A8-7898-48B0-B7FE-297E764B35D8 wds:Q86503109-C00CE91C-850D-489A-A0A4-5C7F55644AC0 wds:Q86503109-CBEDB5F3-1C38-4880-B03C-BD7F21CB733E wds:Q86503109-70CEFA77-B237-421F-AE0A-3CE8E98B4D83 wds:Q86503109-78BDB053-067C-425C-BA5B-74852F9729D2 wds:Q86503109-962F8352-6D8A-4E8B-A71F-FA09AEFBD872 wds:Q86503109-99F39C7F-9E2C-4AA9-B89D-F8BAE85152E8 wds:Q86503109-95C4F646-18C5-43BE-A243-89BBD0E337BF wds:Q86503109-E9EF0769-A78C-4E06-B639-CC51C533E89D wds:Q86503109-E845CF93-54A0-47E8-BB1A-39FAFD54DC59
wdt:P2093
Shamir R Mehta Shaun G Goodman Akshay Bagai Warren J Cantor Charles Lazzam Vladimír Džavík Mary Tan Michael Heffernan Anatoly Langer Wesley Tong Brian Schwartz David Fitchett Andre Lamy Bjug Borgundvaag
rdfs:label
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study
skos:prefLabel
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study
schema:name
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study
p:P50
wds:Q86503109-261AB5D8-0541-4C31-9ACD-54FE4F5B6B57 wds:Q86503109-690664A1-6496-41BB-8F32-E3C347E513CF wds:Q86503109-E95BC6CF-A383-4260-B36D-A091DF2C27BA
wdt:P50
wd:Q51093170 wd:Q88161889 wd:Q93106240
p:P1476
wds:Q86503109-FAEC0049-5F8C-4E60-A9BC-E6163C3C6DDE
wdt:P1476
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study
p:P304
wds:Q86503109-DFDCB88A-3355-422A-9BF9-7832F11CB786
wdt:P304
630-637.e2
p:P31
wds:Q86503109-3B3CF7C5-EAA9-48B6-AB75-46FB2ACB3530
wdt:P31
wd:Q13442814
p:P921
wds:Q86503109-01374713-3F53-46D8-A80B-F8352C9AE9DC wds:Q86503109-2FE5F778-D44F-4E7F-9CC8-C6ED73771B34
wdt:P921
wd:Q18558122 wd:Q539795
p:P698
wds:Q86503109-8B37DFBA-5943-4432-8480-6E5DBA3B09E2
wdtn:P698
n9:23537982
wdt:P698
23537982
p:P1433
wds:Q86503109-075F6633-6239-4DDE-8A00-B1EB8C8925E3
wdt:P1433
wd:Q2227156
p:P433
wds:Q86503109-9A812B4A-C7D1-4CE4-8176-DC00D6B1C77A
p:P478
wds:Q86503109-64B1FE7A-D6C8-44E7-A53C-5C7155D1B53A
wdt:P433
4
wdt:P478
165
p:P356
wds:Q86503109-0D1AFDEF-EBB5-4918-8456-765F92BCF23C
wdtn:P356
n11:J.AHJ.2012.12.016
wdt:P356
10.1016/J.AHJ.2012.12.016